RANI
Rani Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.81 / 10
Netural
Analyst sentiment is overwhelmingly bullish with a Strong Buy rating from one analyst, yet historical win rates are poor (0%). Fund-flow data show a large-cap inflow ratio of 0.507 (positive trend) but overall and block flows are negative (0.486). This mixed flow backdrop—positive in large sizes, negative elsewhere—adds ambiguity and limits conviction.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-09
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate0.0%
Is money flowing into or out of RANI?
- RANI holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.81/10 (Netural).
